The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases
Medical Decision Making - United States
doi 10.1177/0272989x14563082
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 10, 2014
Authors
Publisher
SAGE Publications